Clinical Trial Update: Study to Determine the Efficacy and Safety of Docetaxel and Doxorubicin With INGN 201 in Locally Advanced Breast Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial assesses the efficacy and safety of combining docetaxel, doxorubicin, and INGN 201 in locally advanced breast cancer. The study has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Adriamycin (doxorubicin)
• INGN 201
• Taxotere (docetaxel)

Snippet

Sponsor: Introgen Therapeutics | Conditions: Locally Advanced Breast Cancer (LABC) | Phase 2 | Status: COMPLETED